Transcriptional regulation of interleukin-3 expression in megakaryocytes

Stephen D Nimer, Jin Zhang, Hava Avraham, Yasushi Miyazaki

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Interleukin-3 (IL-3) is a potent stimulator of megakaryocyte proliferation, and autocrine production of IL-3 by megakaryocytic leukemia cell lines and bone marrow-derived megakaryocytes has recently been demonstrated. To characterize the transcriptional regulation of IL-3 in megakaryocytes, we transiently transfected IL-3 promoter CAT constructs that contain variable amounts of 5' flanking sequences into the human CMK and CMK- 6 megakaryocytic cell lines and identified two positive acting transcriptional regulatory regions, one located between bp -315 and -284, which contains consensus AP-1 and ets binding sites, and a second located between bp -173 and -61. DNase I footprinting assays using CMK or CMK-6 nuclear extracts demonstrate DNA-protein interactions in the identical region protected by T cell ornatural killer cell nuclear extracts (between bp -165 to -128), and electrophoretic mobility shift assays demonstrate the binding of proteins to three distinct portions of this region. To characterize the transcription factors in megakaryocytic cells that could bind to these two regulatory regions, we performed Northern blot analyses, which showed the presence of ets-1, elf-1 (which is thought to be restricted to T cells), NF- IL3A and AML1 mRNAs, as well as c-fos, jun B, and jun D, but not c-jun mRNA. These studies show that the transcriptional regulation of IL-3 expression in megakaryocytic leukemia cell lines is similar, but not identical to normal human T cells.

Original languageEnglish
Pages (from-to)66-74
Number of pages9
JournalBlood
Volume88
Issue number1
StatePublished - Jul 1 1996
Externally publishedYes

Fingerprint

Megakaryocytes
Interleukin-3
T-cells
Leukemia, Megakaryoblastic, Acute
Nucleic Acid Regulatory Sequences
Cells
T-Lymphocytes
Cell Line
Assays
Dilatation and Curettage
Electrophoretic mobility
Messenger RNA
5' Flanking Region
Deoxyribonuclease I
Transcription Factor AP-1
Electrophoretic Mobility Shift Assay
Cell Extracts
Northern Blotting
Carrier Proteins
Bone

ASJC Scopus subject areas

  • Hematology

Cite this

Nimer, S. D., Zhang, J., Avraham, H., & Miyazaki, Y. (1996). Transcriptional regulation of interleukin-3 expression in megakaryocytes. Blood, 88(1), 66-74.

Transcriptional regulation of interleukin-3 expression in megakaryocytes. / Nimer, Stephen D; Zhang, Jin; Avraham, Hava; Miyazaki, Yasushi.

In: Blood, Vol. 88, No. 1, 01.07.1996, p. 66-74.

Research output: Contribution to journalArticle

Nimer, SD, Zhang, J, Avraham, H & Miyazaki, Y 1996, 'Transcriptional regulation of interleukin-3 expression in megakaryocytes', Blood, vol. 88, no. 1, pp. 66-74.
Nimer SD, Zhang J, Avraham H, Miyazaki Y. Transcriptional regulation of interleukin-3 expression in megakaryocytes. Blood. 1996 Jul 1;88(1):66-74.
Nimer, Stephen D ; Zhang, Jin ; Avraham, Hava ; Miyazaki, Yasushi. / Transcriptional regulation of interleukin-3 expression in megakaryocytes. In: Blood. 1996 ; Vol. 88, No. 1. pp. 66-74.
@article{f094ef81a1ad471894b88ceb9d2ce231,
title = "Transcriptional regulation of interleukin-3 expression in megakaryocytes",
abstract = "Interleukin-3 (IL-3) is a potent stimulator of megakaryocyte proliferation, and autocrine production of IL-3 by megakaryocytic leukemia cell lines and bone marrow-derived megakaryocytes has recently been demonstrated. To characterize the transcriptional regulation of IL-3 in megakaryocytes, we transiently transfected IL-3 promoter CAT constructs that contain variable amounts of 5' flanking sequences into the human CMK and CMK- 6 megakaryocytic cell lines and identified two positive acting transcriptional regulatory regions, one located between bp -315 and -284, which contains consensus AP-1 and ets binding sites, and a second located between bp -173 and -61. DNase I footprinting assays using CMK or CMK-6 nuclear extracts demonstrate DNA-protein interactions in the identical region protected by T cell ornatural killer cell nuclear extracts (between bp -165 to -128), and electrophoretic mobility shift assays demonstrate the binding of proteins to three distinct portions of this region. To characterize the transcription factors in megakaryocytic cells that could bind to these two regulatory regions, we performed Northern blot analyses, which showed the presence of ets-1, elf-1 (which is thought to be restricted to T cells), NF- IL3A and AML1 mRNAs, as well as c-fos, jun B, and jun D, but not c-jun mRNA. These studies show that the transcriptional regulation of IL-3 expression in megakaryocytic leukemia cell lines is similar, but not identical to normal human T cells.",
author = "Nimer, {Stephen D} and Jin Zhang and Hava Avraham and Yasushi Miyazaki",
year = "1996",
month = "7",
day = "1",
language = "English",
volume = "88",
pages = "66--74",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Transcriptional regulation of interleukin-3 expression in megakaryocytes

AU - Nimer, Stephen D

AU - Zhang, Jin

AU - Avraham, Hava

AU - Miyazaki, Yasushi

PY - 1996/7/1

Y1 - 1996/7/1

N2 - Interleukin-3 (IL-3) is a potent stimulator of megakaryocyte proliferation, and autocrine production of IL-3 by megakaryocytic leukemia cell lines and bone marrow-derived megakaryocytes has recently been demonstrated. To characterize the transcriptional regulation of IL-3 in megakaryocytes, we transiently transfected IL-3 promoter CAT constructs that contain variable amounts of 5' flanking sequences into the human CMK and CMK- 6 megakaryocytic cell lines and identified two positive acting transcriptional regulatory regions, one located between bp -315 and -284, which contains consensus AP-1 and ets binding sites, and a second located between bp -173 and -61. DNase I footprinting assays using CMK or CMK-6 nuclear extracts demonstrate DNA-protein interactions in the identical region protected by T cell ornatural killer cell nuclear extracts (between bp -165 to -128), and electrophoretic mobility shift assays demonstrate the binding of proteins to three distinct portions of this region. To characterize the transcription factors in megakaryocytic cells that could bind to these two regulatory regions, we performed Northern blot analyses, which showed the presence of ets-1, elf-1 (which is thought to be restricted to T cells), NF- IL3A and AML1 mRNAs, as well as c-fos, jun B, and jun D, but not c-jun mRNA. These studies show that the transcriptional regulation of IL-3 expression in megakaryocytic leukemia cell lines is similar, but not identical to normal human T cells.

AB - Interleukin-3 (IL-3) is a potent stimulator of megakaryocyte proliferation, and autocrine production of IL-3 by megakaryocytic leukemia cell lines and bone marrow-derived megakaryocytes has recently been demonstrated. To characterize the transcriptional regulation of IL-3 in megakaryocytes, we transiently transfected IL-3 promoter CAT constructs that contain variable amounts of 5' flanking sequences into the human CMK and CMK- 6 megakaryocytic cell lines and identified two positive acting transcriptional regulatory regions, one located between bp -315 and -284, which contains consensus AP-1 and ets binding sites, and a second located between bp -173 and -61. DNase I footprinting assays using CMK or CMK-6 nuclear extracts demonstrate DNA-protein interactions in the identical region protected by T cell ornatural killer cell nuclear extracts (between bp -165 to -128), and electrophoretic mobility shift assays demonstrate the binding of proteins to three distinct portions of this region. To characterize the transcription factors in megakaryocytic cells that could bind to these two regulatory regions, we performed Northern blot analyses, which showed the presence of ets-1, elf-1 (which is thought to be restricted to T cells), NF- IL3A and AML1 mRNAs, as well as c-fos, jun B, and jun D, but not c-jun mRNA. These studies show that the transcriptional regulation of IL-3 expression in megakaryocytic leukemia cell lines is similar, but not identical to normal human T cells.

UR - http://www.scopus.com/inward/record.url?scp=0030013142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030013142&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 66

EP - 74

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -